161 related articles for article (PubMed ID: 3011131)
1. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S
Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131
[TBL] [Abstract][Full Text] [Related]
2. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
Kashihara K; Sato M; Fujiwara Y; Ogawa T; Fukuda K; Otsuki S
Yakubutsu Seishin Kodo; 1986 Jun; 6(2):275-80. PubMed ID: 3022499
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
4. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
Korpi ER; Wyatt RJ
Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
[TBL] [Abstract][Full Text] [Related]
5. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Toide K; Unemi N; Segawa T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.
Satoh H; Kuwaki T; Shirakawa K; Kohjimoto Y; Ono T; Shibayama F; Nomura Y
Jpn J Pharmacol; 1987 Aug; 44(4):393-403. PubMed ID: 3682405
[TBL] [Abstract][Full Text] [Related]
7. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
8. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
Mjörndal T; Persson SA
Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
[TBL] [Abstract][Full Text] [Related]
9. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
Melamed E; Durst R; Frucht Y; Globus M
Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
[TBL] [Abstract][Full Text] [Related]
11. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
Le Douarin C; Fage D; Scatton B
Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
[TBL] [Abstract][Full Text] [Related]
14. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
[TBL] [Abstract][Full Text] [Related]
15. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
Savasta M; Dubois A; Benavidès J; Scatton B
Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
Bettini E; Ceci A; Spinelli R; Samanin R
Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
[TBL] [Abstract][Full Text] [Related]
17. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
18. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Walters DE; Chapman CD; Howard SG
J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
[TBL] [Abstract][Full Text] [Related]
19. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Schweitzer JW; Schwartz R; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
[TBL] [Abstract][Full Text] [Related]
20. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]